Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies
Sign Up to like & getrecommendations! Published in 2020 at "BioMed Research International"
DOI: 10.1155/2020/4956946
Abstract: As the most common type of cancer in the world, hematological malignancies (HM) account for 10% of all annual cancer deaths and have attracted more attention. Conventional treatments, such as chemotherapy, radiotherapy, and hematopoietic stem… read more here.
Keywords: based immunotherapeutic; antibody based; treatment; antibody ... See more keywords